General Information of This Drug (ID: DMV04ES)

Drug Name
Rotenone   DMV04ES
Synonyms
rotenone; 83-79-4; Paraderil; Dactinol; Tubatoxin; (-)-Rotenone; Barbasco; (-)-cis-Rotenone; Derris; Derrin; Cube root; Rotocide; Nicouline; Rotenon; Noxfish; Ronone; Deril; Canex; Liquid Derris; Cube-Pulver; Dri-Kil; Rotessenol; Rotenox; Rotefive; Noxfire; Rotefour; Mexide; Haiari; Cubor; Derris root; Powder and root; Pro-nox fish; Chem-Mite; Cenol garden dust; Curex flea duster; Prenfish; Prentox; Gerane; Synpren; Ro-Ko; Derris (insecticide); Chem fish; Pb-nox; Rotenox 5EC; 5'-beta-Rotenone; Green Cross Warble Powder; Prentox Synpren-Fish; Chem-Fish S
Indication
Disease Entry ICD 11 Status REF
Piscicide N.A. Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

10 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Abexinostat + Rotenone DCMA4BF Abexinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
AG-881 + Rotenone DCVFR6W AG-881 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
Flucytosine + Rotenone DC1AJYO Flucytosine Embryonal rhabdomyosarcoma (Cell Line: Rh36) [2]
Flucytosine + Rotenone DCZ4CBC Flucytosine Embryonal rhabdomyosarcoma (Cell Line: CTR) [2]
Flucytosine + Rotenone DCR1QK4 Flucytosine Embryonal rhabdomyosarcoma (Cell Line: RD) [2]
Larotrectinib + Rotenone DC96CTX Larotrectinib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
Rotenone + Panobinostat DC2Y0I5 Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
Rotenone + Daporinad DC25JOS Daporinad Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
Rotenone + PAC1 DCPG65E PAC1 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
SGC707 + Rotenone DCXZZLY SGC707 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 DrugCom(s)

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.